Publications by authors named "F D M Warricker"

Objective: To estimate the strength of association between exposure to selected classes of prescribed medications and the risk of developing iron deficiency anaemia (IDA), specifically considering oral anticoagulants (OACs), antidepressants, antiplatelet agents, proton pump inhibitors (PPIs) and non-steroidal anti-inflammatories.

Design: A case-control study involving the analysis of community repeat prescriptions among subjects referred with IDA, and unmatched controls referred as gastroenterology fast-tracks for other indications. Multivariable logistic regression modelling was used to calculate ORs for the association between IDA presentation and each medication class, adjusted for age, sex and coprescribing.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how the COVID-19 pandemic affected routine monitoring of chronic Hepatitis B virus (HBV) patients in the UK, focusing on key biomarkers like alanine transferase (ALT) and HBV viral load.
  • Researchers analyzed anonymized health record data from five NHS Trusts to compare biomarker monitoring before and during the pandemic.
  • Findings showed a significant drop in both the number of patients monitored and the frequency of biomarker measurements during the pandemic, prompting the need for interventions to address these health service disruptions.
View Article and Find Full Text PDF

Natural killer (NK) cells have a key role in host anti-tumour immune responses via direct killing of tumour cells and promotion of adaptive immune responses. They are therefore attractive targets to promote the anti-tumour efficacy of oncolytic viral therapies. However, NK cells are also potent components of the host anti-viral immune response, and therefore have the potential for detrimental anti-viral responses, limiting the spread and persistence of oncolytic viruses.

View Article and Find Full Text PDF

Despite major advances in immunotherapy, hepatocellular carcinoma (HCC) remains a challenging target. Natural Killer (NK) cells are crucial components of the anti-HCC immune response, which can be manipulated for immunotherapeutic benefit as primary targets, modulators of the tumour microenvironment and in synchronising with tumour antigen specific effector CD8 cells for tumour clearance. Regulatory T cells shape the anti-tumour response from effector T cells multiple suppressive mechanisms.

View Article and Find Full Text PDF